ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HCM Hutchmed (china) Limited

310.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 310.00 307.00 310.00 314.00 303.00 311.00 17,440 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 310p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 338.00p.

Hutchmed (china) currently has 871,256,270 shares in issue.

Hutchmed (china) Share Discussion Threads

Showing 876 to 898 of 4100 messages
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older
DateSubjectAuthorDiscuss
17/10/2016
15:34
US institutions won't buy because one of the attractions of biotech is that if a company gets lucky and discovers something big,it will nine times out of ten get taken over!This stock is takeover proof.
steeplejack
13/10/2016
08:18
hmmmm yes!
He still has a large holding and maybe he sold to fund something such as a house purchase but the price drift is frustrating, especially the fact we are down 16% on NASDAQ since the IPO.

Almost no U.S. institutional Investors on board (similar to Beigene). My conclusion is the big U.S. Specialist Funds will not invest because we are a Chinese Company, albeit controlled by a Hong Kong conglomerate.

nerdofsteel
12/10/2016
13:53
Non- exec share sale.He's got bored like the rest of us.
steeplejack
11/10/2016
14:27
Lots of deals taking place, the latest one is Shire to take over Radius. We must get pipeline news shortly...
nerdofsteel
09/10/2016
16:28
surely due some news on the pipeline by now
nerdofsteel
23/9/2016
07:08
got excited there, someone else posting on the board, only to find them snoring!

Interesting that the words shortly, imminently and soon have an entire new meaning of the words compared to their normal use.

nerdofsteel
22/9/2016
07:39
Zzzz Zzzz zzz
steeplejack
21/9/2016
15:19
Big news due very shortly eg. in the next 6 months!!
nerdofsteel
13/9/2016
11:24
Lots of news due, mainly on the pipeline, especially Savolitinib and Fruquintinib. I wonder how the initial presentations and meetings went with the FDA?
nerdofsteel
17/8/2016
09:06
good for me, I continue to buy but I get your point
nerdofsteel
15/8/2016
09:56
Right shoulder of h+s formation?looks like it, not good if so
tsmith2
09/8/2016
10:06
Mr Nash's family buy yet again, clearly he knows how big we will be in the coming decade
nerdofsteel
04/8/2016
08:08
hxxp://stocktwits.com/symbol/HCM?q=HCM
nerdofsteel
03/8/2016
13:53
Anyone come across any US-based discussion forums for HCM?
nahoon
03/8/2016
12:07
True but the tide appears to be turning.The biotech investment trusts are well off their lows.This stock is still suffering the after effects of a poorly handled ADR issue.Certainly as far as UK holders are concerned.
steeplejack
03/8/2016
10:46
Then again Biotech & Biopharma have been out of favour so far this year in the U.S. markets
nerdofsteel
03/8/2016
08:46
Zzzzzz zzzzzz zzzz
steeplejack
02/8/2016
18:40
Brilliant Results, American market still sleeping
nerdofsteel
02/8/2016
07:02
Indeed, and the American market seems to be in a deep sleep

Let's hope the H1 results are well received today

nerdofsteel
01/8/2016
08:56
Very good news this morning though you would never guess it from the share price.
miti 1000
30/7/2016
13:53
Very much Looking forward to H1 results on Tuesdy
nerdofsteel
21/6/2016
11:15
interesting, and Savolitinib in NSLC alone could result in global sales attributable to Chi-Med if circa $180m pa. peak sales
nerdofsteel
09/6/2016
10:41
Thanks nerdsofsteelTheir valuation translates into about £26
nfs
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older

Your Recent History

Delayed Upgrade Clock